Karina Zuck

Company: US Food & Drug Administration (FDA)

Job title: Chemist

Seminars:

Regulatory Considerations for Antibody-Drug Conjugates From the Small Molecule Perspective 9:30 am

Overview of the review process for ADC products, with a focus on the small molecule Review expectations on payload-linker controls Discuss the expectations on DAR and residual impurities controls in the ADC drug substances and drug productsRead more

day: Day One